乳腺癌:分子病原和向治疗
Md Abdus Samad1,2, Iftikhar Ahmad1,2, Mohammad Rashid Khan3
1Department of Biochemistry Faculty of Science King Abdulaziz University Jeddah Saudi Arabia.
创新的乳腺癌 (BC) 疗法正在出现,以打击治疗耐药性和复发. 针对性治疗,免疫疗法以及人工智能和液体活检等新方法的进步旨在改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 精准医学是一门精准的医学.
背景情况:
- 乳腺癌 (BC) 是女性癌症死亡的主要原因,由复杂的因素驱动,包括遗传学和信号通路变化.
- 瘤异质性,治疗耐药性和复发性需要开发新的治疗策略,以有效管理乳腺癌.
研究的目的:
- 审查乳腺癌的创新治疗方法.
- 突出针对性疗法,免疫调节策略和塑造BC治疗的新兴技术的进展.
主要方法:
- 审查目前的瘤学研究,重点关注向疗法 (例如CDK 4/6抑制剂,PARP抑制剂) 和免疫疗法 (例如免疫检查点抑制剂).
- 探索新的策略,包括准瘤内异质性,用于检测耐药性的液体活检,基于AI的药物发现,患者衍生器官和自适应性试验设计.
主要成果:
- 向疗法和免疫疗法在克服BC耐药性方面表现有前途.
- 像液体活检和人工智能驱动的药物发现等创新方法对于个性化治疗策略至关重要.
- 新兴的方法解决了诸如治疗耐药性等挑战,并提高了治疗疗效.
结论:
- 将分子洞察力与精密治疗方法相结合,为改善乳腺癌治疗疗效和患者治疗结果提供了显著的潜力.
- 新的策略对于克服乳腺癌的治疗耐药性和复发至关重要.
- 结核病治疗的进步正在朝着更个性化,更有效的患者护理迈进.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mitogens and the Cell Cycle
Treatment Resistant Cancers
Cancer
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
